Manufacturer
GLAXOSMITHKLINE BIOLOGICALS S.A
Contents
Per 0.5 mL Diphtheria toxoid not <30 IU, tetanus toxoid not <40 IU, pertussis toxoid 25 mcg, filamentous haemagglutinin 25 mcg, pertactin 8 mcg, inactivated polio virus [type 1 (Mahoney) 40 D-antigen unit, type 2 (MEF-1) 8 D-antigen unit, type 3 (Saukett) 32 D-antigen unit]; HIB polysaccharide 10 mcg (conjugated to tetanus toxoid approx 30 mcg)
Indication
Active immunisation in infants from 2 mth against DPT, poliomyelitis & HIB. Booster dose for childn previously immunised w/ DTP, polio & Hib antigens.
Instruction
Deep IM inj Primary vaccination 3 doses of 0.5 mL at 1st 6 mth of life, starting from 2 mth w/ at least 1 mth interval between subsequent doses. Booster dose Given in the 2nd yr of life w/ at least 6-mth interval after completion of primary vaccination schedule.
Drug interaction
Adequate response may not be achieved w/ immunosuppressive therapy.
Malaysia
